Riyad Capital Lowers Nahdi Medical's PT, Maintains Neutral Rating

MT Newswires · 1d ago
08:37 AM EDT, 08/07/2026 (MT Newswires) -- Riyad Capital on Thursday decreased the price target for retail pharmacy and healthcare company Nahdi Medical (SASE:4164) to 100 Saudi riyals from 105 riyals and reiterated its neutral rating. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)